FI20115576A0 - Menetelmä Alzheimerin taudin diagnoimiseksi - Google Patents

Menetelmä Alzheimerin taudin diagnoimiseksi

Info

Publication number
FI20115576A0
FI20115576A0 FI20115576A FI20115576A FI20115576A0 FI 20115576 A0 FI20115576 A0 FI 20115576A0 FI 20115576 A FI20115576 A FI 20115576A FI 20115576 A FI20115576 A FI 20115576A FI 20115576 A0 FI20115576 A0 FI 20115576A0
Authority
FI
Finland
Prior art keywords
disease
diagnosing alzheimer
alzheimer
diagnosing
Prior art date
Application number
FI20115576A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Matej Oreeic
Hilkka Soininen
Tuulia Hyoetylaeinen
Original Assignee
Teknologian Tutkimuskeskus Vtt Oy
Itae Suomen Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teknologian Tutkimuskeskus Vtt Oy, Itae Suomen Yliopisto filed Critical Teknologian Tutkimuskeskus Vtt Oy
Priority to FI20115576A priority Critical patent/FI20115576A0/fi
Publication of FI20115576A0 publication Critical patent/FI20115576A0/fi
Priority to PCT/FI2012/050571 priority patent/WO2012168561A1/en
Priority to EP12735315.9A priority patent/EP2718729A1/en
Priority to JP2014514121A priority patent/JP2014521928A/ja
Priority to US14/125,091 priority patent/US20140165700A1/en
Priority to KR1020147000722A priority patent/KR20140043782A/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
FI20115576A 2011-06-10 2011-06-10 Menetelmä Alzheimerin taudin diagnoimiseksi FI20115576A0 (fi)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20115576A FI20115576A0 (fi) 2011-06-10 2011-06-10 Menetelmä Alzheimerin taudin diagnoimiseksi
PCT/FI2012/050571 WO2012168561A1 (en) 2011-06-10 2012-06-08 Method of diagnosing on increased risk of alzheimer's disease
EP12735315.9A EP2718729A1 (en) 2011-06-10 2012-06-08 Method of diagnosing on increased risk of alzheimer's disease
JP2014514121A JP2014521928A (ja) 2011-06-10 2012-06-08 アルツハイマー病のリスクの増加を診断するための方法
US14/125,091 US20140165700A1 (en) 2011-06-10 2012-06-08 Method of diagnosing on increased risk of alzheimer's disease
KR1020147000722A KR20140043782A (ko) 2011-06-10 2012-06-08 알츠하이머병의 증가된 위험도를 진단하는 방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20115576A FI20115576A0 (fi) 2011-06-10 2011-06-10 Menetelmä Alzheimerin taudin diagnoimiseksi

Publications (1)

Publication Number Publication Date
FI20115576A0 true FI20115576A0 (fi) 2011-06-10

Family

ID=44206787

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20115576A FI20115576A0 (fi) 2011-06-10 2011-06-10 Menetelmä Alzheimerin taudin diagnoimiseksi

Country Status (6)

Country Link
US (1) US20140165700A1 (ko)
EP (1) EP2718729A1 (ko)
JP (1) JP2014521928A (ko)
KR (1) KR20140043782A (ko)
FI (1) FI20115576A0 (ko)
WO (1) WO2012168561A1 (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2592422A1 (en) * 2011-11-08 2013-05-15 Zora Biosciences OY Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
US20160178642A1 (en) * 2013-06-28 2016-06-23 Mcbi Inc. Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
US20160195547A1 (en) * 2013-07-31 2016-07-07 Pharnext Diagnostic tools for alzheimer's disease
WO2015020523A1 (en) * 2013-08-07 2015-02-12 Stichting Vu-Vumc Biomarkers for early diagnosis of alzheimer's disease
EP3060305B1 (en) * 2013-10-21 2019-04-03 Georgetown University Biomarkers for memory loss
US10761100B2 (en) 2014-07-01 2020-09-01 Brigham Young University Systems, assays, and methods for determining risk factors for Alzheimer's disease
BR112017006593A2 (pt) 2014-10-02 2017-12-19 Zora Biosciences Oy método para detectar câncer de ovário
WO2016124574A1 (en) 2015-02-03 2016-08-11 Pharnext Diagnostic tools for alzheimer's disease
US10900980B2 (en) 2015-05-18 2021-01-26 Georgetown University Metabolic biomarkers for memory loss
WO2018008763A1 (ja) * 2016-07-08 2018-01-11 味の素株式会社 アルツハイマー型認知症の将来の発症リスクの評価方法
AU2019320619B2 (en) * 2018-10-30 2021-10-14 Kurume Research Park Co., Ltd. Disease risk assessment apparatus, disease risk assessment method, program, and food for dementia prevention
JP7379862B2 (ja) * 2019-05-09 2023-11-15 株式会社島津製作所 短鎖塩素化パラフィンの同族体の検出方法
JP2022536523A (ja) * 2019-06-12 2022-08-17 ハンティントン メディカル リサーチ インスティテューツ アルツハイマー病の評価および処置のための方法、ならびにその適用
CN111721859A (zh) * 2020-06-05 2020-09-29 珠海沅芷健康科技有限公司 基于超高效液相串联高分辨质谱的早期阿尔茨海默病鼠脂质组学分析方法及应用
CN111679018B (zh) * 2020-08-14 2020-11-20 宝枫生物科技（北京）有限公司 用于诊断认知障碍的生物标记物及其应用
CN111929430B (zh) * 2020-08-14 2021-09-17 宝枫生物科技（北京）有限公司 用于诊断认知障碍的生物标记物及其应用
WO2022210606A1 (ja) * 2021-03-29 2022-10-06 味の素株式会社 認知症の将来の発症リスクの評価方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469486A1 (en) 2001-12-10 2003-06-19 Washington University Diagnostic for early stage alzheimer's disease
WO2006108051A2 (en) * 2005-04-05 2006-10-12 Neurodx, Llc Compositions and methods relating to alzheimer's disease
WO2007050318A2 (en) * 2005-10-24 2007-05-03 Duke University Lipidomics approaches for central nervous system disorders
AU2009326857B2 (en) * 2008-12-09 2016-05-26 Stephanie Fryar-Williams Novel biomarkers

Also Published As

Publication number Publication date
JP2014521928A (ja) 2014-08-28
US20140165700A1 (en) 2014-06-19
EP2718729A1 (en) 2014-04-16
KR20140043782A (ko) 2014-04-10
WO2012168561A1 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
FI20115576A0 (fi) Menetelmä Alzheimerin taudin diagnoimiseksi
IL231620A0 (en) A method for diagnosing Alzheimer's disease
DK3448034T3 (da) Fremgangsmåde til at udlede bevægelsesinformation
ZA201404500B (en) Methods for diagnosing alzheimer's disease
FR2981857B1 (fr) Machine d'exercice
BR112013010351A2 (pt) aparelho de formação de imagem
FR3001166B1 (fr) Procede de rechargement d'une piece
FR2976914B1 (fr) Structure d'accrochage d'une turbomachine
BR112012022750A2 (pt) "método de produção de radionuclídeos"
BR112014001383A2 (pt) aparelho de formação de imagem
BR112013032352A2 (pt) doença tromboembólica
HK1179143A1 (zh) 用於對疾病進行成像的方法
IL230441A0 (en) Diagnosis of Alzheimer's disease
EP2742865A4 (en) METHOD FOR TESTING TOOTH TISSUE DISORDERS
IL231982B (en) A method for the diagnosis of Niemann-Pick disease
DK2729631T3 (da) Fremgangsmåde til at konstruere en tredimensionel opadvendt konveks ramme
DK3318881T3 (da) Fremgangsmåde til overvågning af Gaucher's sygdom
EP2791676A4 (en) PROCESS FOR THE DIAGNOSIS OF MORBUS ALZHEIMER
FI20115709A0 (fi) Menetelmä perinnöllisten syöpien diagnosointiin
FR2990242B1 (fr) Procede de demontage d'un turboreacteur
FR2987085B1 (fr) Procede de securisation du fonctionnement d'une turbomachine
FI20116047L (fi) Menetelmä terveyskortin hallinnoimiseksi
FR2988585B1 (fr) Plaque viscerale destinee a la coelioscopie
EP2615458A4 (en) METHOD FOR DIAGNOSIS OF ALZHEIMER WITH A BLOOD SOLUBLE GPVI
FR2979732B1 (fr) Procede de redimensionnement de l'affichage

Legal Events

Date Code Title Description
FD Application lapsed